Colombia · Spanish · INVIMA
INVIMA translation, aligned to Colombian regulatory practice.
What Colombia's INVIMA expects from Spanish clinical trial and registration documentation — and how an Amavita pilot delivers a package that clears first-cycle review without avoidable requerimientos.
What this covers
INVIMA in three moving parts.
What must be in Colombian Spanish
Protocol, informed consent, investigator's brochure, safety narratives, IFUs, and labeling — using Colombian medical usage rather than neutral or Peninsular Spanish.
Certification and legalization
Legal instruments filed with INVIMA require an official translation by a traductor oficial recognized by the Ministerio de Relaciones Exteriores; apostille and consular legalization rules apply to foreign-origin documents.
Where submissions stall
Inconsistent INN usage, dosing rendered literally from English, and missing appendix translations trigger requerimientos and restart the review clock.
What must be in Colombian Spanish
Protocol, informed consent, investigator's brochure, safety narratives, IFUs, and labeling — using Colombian medical usage rather than neutral or Peninsular Spanish.
Certification and legalization
Legal instruments filed with INVIMA require an official translation by a traductor oficial recognized by the Ministerio de Relaciones Exteriores; apostille and consular legalization rules apply to foreign-origin documents.
Where submissions stall
Inconsistent INN usage, dosing rendered literally from English, and missing appendix translations trigger requerimientos and restart the review clock.
How INVIMA compares to the rest of the world.
INVIMA does not set its rules in isolation. Our primary-source review of preclinical translation requirements across nine LATAM regulators places Colombia on the same three-tier map used above, so you can see where INVIMA is stricter — and where it is more permissive — than its neighbours.
Outside the region the picture changes again. The companion study of preclinical translation rules at eight non-LATAM regulators, from FDA and EMA to PMDA, NMPA, MHRA, Health Canada, TGA and Swissmedic found no primary instrument requiring visual replication of a Module 4 study report, which is why the sworn-translation ceiling described on this page is a LATAM-native construct.
If you are budgeting a multi-country programme, read the three-tier framework for INVIMA preclinical translation in the LATAM regulator study before deciding what to translate for Colombia.
Ready to scope your Colombia pilot?
Start the pilot form and get a timeline in 2 business days.
Frequently asked
INVIMA translation, quick answers.
What language does INVIMA require for clinical trial submissions in Colombia?
INVIMA reviews dossiers in Spanish. Protocols, informed consent forms, investigator's brochures, safety narratives, and product labeling must be translated into Colombian Spanish, with source-language documents accepted only when paired with a compliant translation that preserves numbering, cross-references, and appendices.
Who is authorized to certify translations for INVIMA?
Legal instruments — powers of attorney, corporate authorizations, apostilled documents — must be translated by a traductor oficial recognized by Colombia's Ministerio de Relaciones Exteriores. Technical documents such as protocols and investigator brochures should be prepared by qualified medical translators and reviewed by clinicians familiar with Colombian regulatory usage.
How does the Amavita pilot cover INVIMA submissions?
A pilot scopes one protocol or dossier for Colombia, delivers an MD-reviewed Spanish package aligned to INVIMA expectations, and includes a pre-submission QC checklist covering terminology, formatting, and certification requirements.
Next step
Scope a Colombia pilot this quarter.
Share your Colombia protocol or registration dossier. Our team will reach out within 2 business days with a scoped pilot proposal and timeline.